A Survey of Cannabis Use in a Large US-Based Cohort of People with Multiple Sclerosis.

ABSTRACT:

Background

As cannabis products become increasingly accessible across the United States, it is important to understand the contemporary use of cannabis for managing multiple sclerosis (MS) symptoms.

Methods

We invited participants with MS from the North American Research Committee on Multiple Sclerosis (NARCOMS) Registry (aged 18 years or older) to complete a supplemental survey on cannabis use between March and April 2020. Participants reported cannabis use, treated symptoms, patterns, preferences, methods of use, and the factors limiting use. Findings are reported using descriptive statistics.

Results

Of the 6934 participants invited, 3249 responded. Of the respondents, 31% reported having ever used cannabis to treat MS symptoms, with 20% currently using cannabis. T

SUBMITTER: Salter A 

PROVIDER: S-EPMC8745229 | biostudies-literature | 2021 Nov-Dec

REPOSITORIES: biostudies-literature